Phil Tennant Net Worth

Insiders trading at Precigen Inc

Over the last 5 years, insiders at Precigen Inc have traded over $44,216,787 worth of Precigen Inc stock and bought 52,689,457 units worth $114,197,137 . The most active insiders traders include Randal J Kirk, Trading S.A. Ares oraz Helen Sabzevari. On average, Precigen Inc executives and independent directors trade stock every 9 days with the average trade being worth of $358,866. The most recent stock trade was executed by Randal J Kirk on 9 August 2024, trading 23,529,411 units of PGEN stock currently worth $19,999,999.

What does Precigen Inc do?

precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua

Precigen Inc executives and stock owners

Precigen Inc executives and other stock owners filed with the SEC include:

• Randal Kirk,
  Executive Chairman of the Board
• Dr. Helen Sabzevari MPH, Ph.D.,
  Pres, CEO & Director
• Donald Lehr,
  Chief Legal Officer
• Rick Sterling,
  Chief Financial Officer
• Jeffrey Perez,
  Senior Vice President - Intellectual Property Affairs
• Helen Sabzevari,
  President, Chief Executive Officer, President - Precigen, Inc.
• Donald P. Lehr,
  Chief Legal Officer & Corp. Sec.
• Jeffrey Thomas Perez,
  Sr. VP of Intellectual Property Affairs
• Jeffrey Kindler,
  Independent Director
• Robert Shapiro,
  Lead Independent Director
• Cesar Alvarez,
  Independent Director
• James Turley,
  Independent Director
• Dean Mitchell,
  Independent Director
• Fred Hassan,
  Independent Director
• Vinita Gupta,
  Independent Director
• Steven Frank,
  Independent Director
• Marie Rossi,
  VP of Communications
• Steven Harasym,
  Head of Investor Relations
• James Vincent Lambert,
  Interim Principal Accounting Officer
• Rutul R. Shah,
  Head of Operations & Portfolio
• Harry Thomasian Jr.,
  Chief Financial Officer
• Dr. Thomas D. Reed,
  Founder & Chief Science Officer
• Randal J. Kirk,
  Exec. Chairman
• Harry Jr. Thomasian,
  Chief Financial Officer
• Nancy H Agee,
  Director
• Rutul R Shah,
  Chief Operating Officer
• D. Bradford Osborne,
  VP, Finance and Accounting
• Trading S.A. Ares,
  10% owner
• Phil Tennant,
  Chief Commercial Officer